131 related articles for article (PubMed ID: 1748422)
21. Quantitation of antigens in normal and malignant ovarian tissue.
Knauf S; Urbach GI
Am J Obstet Gynecol; 1975 Oct; 123(3):302-4. PubMed ID: 1180293
[TBL] [Abstract][Full Text] [Related]
22. Tumour-associated antigens for cystadenocarcinoma of the ovary.
Barlow JJ; Bhattacharya M
Clin Obstet Gynaecol; 1983 Aug; 10(2):187-96. PubMed ID: 6413113
[TBL] [Abstract][Full Text] [Related]
23. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
Rao GS; Hanjani P
Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
[TBL] [Abstract][Full Text] [Related]
25. Tumor markers for ovarian cancer.
Bhattacharya M; Barlow JJ
Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
[TBL] [Abstract][Full Text] [Related]
26. Tumor markers in ovarian cancer: tumor-associated antigens.
Barlow JJ; Bhattacharya M
Semin Oncol; 1975 Sep; 2(3):203-9. PubMed ID: 827023
[No Abstract] [Full Text] [Related]
27. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
[TBL] [Abstract][Full Text] [Related]
28. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
[TBL] [Abstract][Full Text] [Related]
29. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
[TBL] [Abstract][Full Text] [Related]
30. Tumor marker in ovarian cancer. Tumor-associated antigen.
Barlow JJ; Bhattacharya M
N Y State J Med; 1977 Mar; 77(3):342-3. PubMed ID: 265013
[No Abstract] [Full Text] [Related]
31. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
32. Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer.
Kudlacek S; Schieder K; Kölbl H; Neunteufel W; Nowotny C; Breitenecker G; Biegelmayer G; Vetterlein M; Fürlinger B; Micksche M
Gynecol Oncol; 1989 Dec; 35(3):323-9. PubMed ID: 2480931
[TBL] [Abstract][Full Text] [Related]
33. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
Faiferman I; Gleicher N; Cohen CJ; Koffler D
J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
35. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of feline ovarian antiserum.
Chan SY; Wildt DE; Chakraborty PK
Am J Vet Res; 1981 Aug; 42(8):1322-7. PubMed ID: 6794393
[TBL] [Abstract][Full Text] [Related]
37. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
38. CA54/61 as a marker for epithelial ovarian cancer.
Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381
[TBL] [Abstract][Full Text] [Related]
39. Ovarian tumor antigens.
Bhattacharya M; Barlow JJ
Cancer; 1978 Sep; 42(3 Suppl):1616-20. PubMed ID: 81712
[TBL] [Abstract][Full Text] [Related]
40. Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer--a study on 674 patients.
Takahashi K; Shibukawa T; Moriyama M; Shirai T; Kijima S; Iwanari O; Matsunaga I; Kitao M
Jpn J Surg; 1986 Sep; 16(5):305-10. PubMed ID: 3467109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
